HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer

Cancer Medicine

Volumn 5, Issue 7, 2016, Pages 1588-1598

  Chai, Yiqing ^a   Liu, Jie ^a   Zhang, Zhikun ^a   Liu, Liwei ^b  

^a Tianjin Central Hospital of Gynecology Obstetrics   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

HuR; lncRNA; miR 124; NEAT1; ovarian cancer

Indexed keywords

ELAV LIKE PROTEIN 1; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA 124; MICRORNA 124-3P; NUCLEAR PARASPECKLE ASSEMBLY TRANSCRIPT 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ECTOPIC EXPRESSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; UPREGULATION;

EID: 85006207128     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.710     Document Type: Article

References (38)

1. Raspaglio, G., I. De Maria, F. Filippetti, E. Martinelli, G. F. Zannoni, S. Prislei, et al. 2010. HuR regulates beta-tubulin isotype expression in ovarian cancer. Cancer Res. 70:5891–5900.
2. Cheng, Z., J. Guo, L. Chen, N. Luo, W. Yang, and X. Qu. 2015. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer. Oncotarget 6:25381–25389.
3. Wilusz, J. E. 2016. Long noncoding RNAs: re-writing dogmas of RNA processing and stability. Biochim. Biophys. Acta 1859:128–138.
4. Zhu, J., H. Fu, Y. Wu, and X. Zheng. 2013. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci. China Life Sci. 56:876–885.
5. Bassett, A. R., A. Akhtar, D. P. Barlow, A. P. Bird, N. Brockdorff, D. Duboule, et al. 2014. Considerations when investigating lncRNA function in vivo. eLife 3:e03058.
6. Qiu, J. J., Y. Wang, J. X. Ding, H. Y. Jin, G. Yang, and K. Q. Hua. 2015. The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis. Exp. Cell Res. 333:238–248.
7. Bhan, A., and S. S. Mandal. 2015. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim. Biophys. Acta 1856:151–164.
8. Li, H., J. An, M. Wu, Q. Zheng, X. Gui, T. Li, et al. 2015. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2. Oncotarget 6:27847–27864.
9. Loewen, G., J. Jayawickramarajah, Y. Zhuo, and B. Shan. 2014. Functions of lncRNA HOTAIR in lung cancer. J. Hematol. Oncol. 7:90.
10. Zhang, A., J. C. Zhao, J. Kim, K. W. Fong, Y. A. Yang, D. Chakravarti, et al. 2015. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 13:209–221.
11. Dong, Y., G. Liang, B. Yuan, C. Yang, R. Gao, and X. Zhou. 2015. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 36:1477–1486.
12. Weber, D. G., G. Johnen, S. Casjens, O. Bryk, B. Pesch, K. H. Jockel, et al. 2013. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res. Notes 6:518.
13. Guo, F., F. Jiao, Z. Song, S. Li, B. Liu, H. Yang, et al. 2015. Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro. Biochem. Biophys. Res. Commun. 465:293–298.
14. Wei, Y., and B. Niu. 2015. Role of MALAT1 as a prognostic factor for survival in various cancers: a systematic review of the literature with meta-analysis. Dis. Markers 2015:164635.
15. Sheng, X., J. Li, L. Yang, Z. Chen, Q. Zhao, L. Tan, et al. 2014. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol. Rep. 32:277–285.
16. Yin, D. D., Z. J. Liu, E. Zhang, R. Kong, Z. H. Zhang, and R. H. Guo. 2015. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol. 36:4851–4859.
17. Peng, W., S. Si, Q. Zhang, C. Li, F. Zhao, F. Wang, et al. 2015. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J. Exp. Clin. Cancer Res. 34:79.
18. Sun, M., R. Xia, F. Jin, T. Xu, Z. Liu, W. De, et al. 2014. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 35:1065–1073.
19. Zhen, L., L. Yun-Hui, D. Hong-Yu, M. Jun, and Y. Yi-Long. 2015. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol. [Epub ahead of print].
20. Chakravarty, D., A. Sboner, S. S. Nair, E. Giannopoulou, R. Li, S. Hennig, et al. 2014. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat. Commun. 5:5383.
21. Choudhry, H., A. Albukhari, M. Morotti, S. Haider, D. Moralli, J. Smythies, et al. 2015. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene 34:4546.
22. Li, Y., Y. Li, W. Chen, F. He, Z. Tan, J. Zheng, et al. 2015. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 6:27641–27650.
23. Hu, X., J. Bao, Z. Wang, Z. Zhang, P. Gu, F. Tao, et al. 2015. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumour Biol. [Epub ahead of print].
24. Lebedeva, S., M. Jens, K. Theil, B. Schwanhausser, M. Selbach, M. Landthaler, et al. 2011. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 43:340–352.
25. Naganuma, T., and T. Hirose. 2013. Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol. 10:456–461.
26. Imamura, K., N. Imamachi, G. Akizuki, M. Kumakura, A. Kawaguchi, K. Nagata, et al. 2014. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol. Cell 53:393–406.
27. Standaert, L., C. Adriaens, E. Radaelli, A. Van Keymeulen, C. Blanpain, T. Hirose, et al. 2014. The long noncoding RNA Neat1 is required for mammary gland development and lactation. RNA 20:1844–1849.
28. Blume, C. J., A. Hotz-Wagenblatt, J. Hullein, L. Sellner, A. Jethwa, T. Stolz, et al. 2015. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia 29:2015–2023.
29. Guo, S., W. Chen, Y. Luo, F. Ren, T. Zhong, M. Rong, et al. 2015. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. Int. J. Clin. Exp. Pathol. 8:5395–5402.
30. Abdelmohsen, K., and M. Gorospe. 2010. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA 1:214–229.
31. Srikantan, S., and M. Gorospe. 2012. HuR function in disease. Front Biosci. 17:189–205.
32. Denkert, C., W. Weichert, S. Pest, I. Koch, D. Licht, M. Köbel, et al. 2004. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 64:189–195.
33. Davidson, B., A. Holth, E. Hellesylt, R. Hadar, B. Katz, C. G. Tropé, et al. 2016. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival. Hum. Pathol. 48:95–101.
34. Liz, J., and M. Esteller. 2016. lncRNAs and microRNAs with a role in cancer development. Biochim. Biophys. Acta 1859:169–176.
35. Guil, S., and M. Esteller. 2015. RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem. Sci. 40:248–256.
36. Sun, Y., Z. M. Luo, X. M. Guo, D. F. Su, and X. Liu. 2015. An updated role of microRNA-124 in central nervous system disorders: a review. Front. Cell. Neurosci. 9:193.
37. Arabkheradmand, A., A. Safari, M. Seifoleslami, E. Yahaghi, and M. Gity. 2015. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Diagn. Pathol. 10:178.
38. Taniguchi, K., N. Sugito, M. Kumazaki, H. Shinohara, N. Yamada, Y. Nakagawa, et al. 2015. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett. 363:17–27.